Agenda Details | ASGCT Annual Meeting

Detailed Program

Tuesday, May 16 2023
01:30 PM – 03:15 PM PT

Tumor Microenvironment as a Barrier to the Success of Immunotherapies and Strategies to Overcome

In this session, we will review the mechanisms of tumor microenvironment induced inhibition of immunotherapy and discuss novel strategies to overcome this inhibition through T cell engineering, reprogramming of tumor microenvironment and utilization of oncolytic virus combination therapies.

Session Details

01:30 PM – 03:15 PM - Concourse Hall 150 & 151

Co-Chair

Saad Kenderian, M.D.. Mayo Clinic, Rochester, MN

01:30 PM – 03:15 PM - Concourse Hall 150 & 151

Co-Chair

Sunil S. Raikar, MD. Emory University, Atlanta, GA

01:31 PM – 01:55 PM - Concourse Hall 150 & 151

Review of Current Status of Tumor Immunologies and Obstacles to Tumor Microenvironment

Maria G.. Castro, PhD. University of Michigan Medical School, Ann Arbor, MI

01:55 PM – 02:20 PM - Concourse Hall 150 & 151

Armoring T-cells

Joseph A. Fraietta, PhD. University of Pennsylvania, PA

02:20 PM – 02:45 PM - Concourse Hall 150 & 151

In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases

Mario Leonardo Squadrito. San Raffaele Telethon Institute for Gene Therapy, Italy

02:45 PM – 03:10 PM - Concourse Hall 150 & 151

Combinational Oncolytic Viruses

Paola Grandi, PhD, MBA. CG Oncology, Irivne, CA